Proton pump inhibitors and vascular function: A prospective cross-over pilot study

Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population

(2015) Nigam H. Shah et al.   PLoS One

Response to Letters Regarding Article, “Unexpected Effect of Proton Pump Inhibitors: Elevation of the Cardiovascular Risk Factor Asymmetric Dimethylarginine”

(2014) Yohannes T. Ghebremariam et al.   CIRCULATION

Proton-Pump Inhibitors Are Associated With Increased Cardiovascular Risk Independent of Clopidogrel Use

(2013) Mette Charlot   ANNALS OF INTERNAL MEDICINE

Unexpected Effect of Proton Pump Inhibitors

(2013) Yohannes T. Ghebremariam et al.   CIRCULATION

Association of Proton Pump Inhibitor Use on Cardiovascular Outcomes With Clopidogrel and Ticagrelor

(2012) Shaun G. Goodman et al.   CIRCULATION

No consistent evidence of differential cardiovascular risk amongst proton-pump inhibitors when used with clopidogrel: Meta-analysis

(2012) Chun Shing Kwok et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Risk prediction in cardiovascular disease: The prognostic significance of endothelial dysfunction

(2011) Billie-Jean Martin et al.   CANADIAN JOURNAL OF CARDIOLOGY

Plasma asymmetric dimethylarginine predicts death and major adverse cardiovascular events in individuals referred for coronary angiography

(2011) Tse-Min Lu et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Dietary nitrate supplementation enhances exercise performance in peripheral arterial disease

(2011) Aarti A. Kenjale et al.   JOURNAL OF APPLIED PHYSIOLOGY

Dietary nitrate, nitric oxide, and restenosis

(2011) John P. Cooke et al.   JOURNAL OF CLINICAL INVESTIGATION

Pharmacological management of GERD: where does it stand now?

(2011) Tiberiu Hershcovici et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

A novel predictor of restenosis and adverse cardiac events: asymmetric dimethylarginine

(2010) Hasan Ari et al.   HEART AND VESSELS

Asymmetric dimethylarginine correlates with measures of disease severity, major adverse cardiovascular events and all-cause mortality in patients with peripheral arterial disease

(2010) Andrew M Wilson et al.   VASCULAR MEDICINE

A population-based study of the drug interaction between proton pump inhibitors and clopidogrel

(2009) D. N. Juurlink et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Plasma Asymmetric Dimethylarginine and Incidence of Cardiovascular Disease and Death in the Community

(2009) Rainer H. Böger et al.   CIRCULATION

Endothelial Dysfunction as a Target for Prevention of Cardiovascular Disease

(2009) D. Versari et al.   DIABETES CARE

Proton-Pump Inhibitor Therapy Induces Acid-Related Symptoms in Healthy Volunteers After Withdrawal of Therapy

(2009) Christina Reimer et al.   GASTROENTEROLOGY

Risk of Adverse Outcomes Associated With Concomitant Use of Clopidogrel and Proton Pump Inhibitors Following Acute Coronary Syndrome

(2009) P. Michael Ho   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

High-throughput ambulatory assessment of digital reactive hyperemia: Concurrent validity with known cardiovascular risk factors and potential confounding

(2009) Elisabeth Truschel et al.   PREVENTIVE MEDICINE

Influence of Omeprazole on the Antiplatelet Action of Clopidogrel Associated With Aspirin

(2008) Martine Gilard et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY